https://news.medxy.ai/zh/elderly-hr-positive-breast-cancer/Medxy AIzh2026-10-04T04:34:10-07:00老年cT2N0 HR+/HER2-乳腺癌女性中前哨淋巴结活检的再评估：对治疗决策影响有限 https://news.medxy.ai/ja/sentinel-lymph-node-biopsy-4/Medxy AIja2026-10-04T04:33:52-07:00高齢女性のcT2N0 HR+/HER2-乳癌におけるセンチネルリンパ節生検を再考する：治療方針への影響は限定的 https://news.medxy.ai/vi/sentinel-node-biopsy-role/Medxy AIvi2026-10-04T04:33:33-07:00Có nên làm lại vai trò của sinh thiết hạch lính gác ở phụ nữ lớn tuổi mắc ung thư vú cT2N0 HR+/HER2-? Ảnh hưởng đến quyết định điều trị còn rất hạn chế https://news.medxy.ai/reevaluating-sentinel-lymph-node-biopsy-in-older-women-with-ct2n0-hr-her2-breast-cancer-limited-impact-on-treatment-decisions/Medxy AIen2026-10-04T04:33:14-07:00Reevaluating Sentinel Lymph Node Biopsy in Older Women with cT2N0 HR+/HER2- Breast Cancer: Limited Impact on Treatment Decisions https://news.medxy.ai/zh/80682-2/Medxy AIzh2026-10-04T04:32:37-07:00妇科肿瘤中的免疫疗法诱导性内分泌功能障碍：一项回顾性队列研究的临床见解 https://news.medxy.ai/ja/immune-therapy-endocrine-disorders/Medxy AIja2026-10-04T04:32:16-07:00婦人科腫瘍における免疫療法誘発性内分泌障害：後ろ向きコホート研究から得られた臨床的知見 https://news.medxy.ai/vi/80677-2/Medxy AIvi2026-10-04T04:31:50-07:00Rối loạn chức năng nội tiết do liệu pháp miễn dịch trong ung thư phụ khoa: Những hiểu biết lâm sàng từ nghiên cứu đoàn hệ hồi cứu https://news.medxy.ai/immunotherapy-induced-endocrine-dysfunction-in-gynecologic-oncology-clinical-insights-from-a-retrospective-cohort-study/Medxy AIen2026-10-04T04:31:28-07:00Immunotherapy-Induced Endocrine Dysfunction in Gynecologic Oncology: Clinical Insights from a Retrospective Cohort Study https://news.medxy.ai/zh/serum-glp-1/Medxy AIzh2026-10-04T04:30:38-07:00血清 GLP-1：肥胖女性子宫内膜癌筛查的新型生物标志物 https://news.medxy.ai/ja/glp-1-biomarker/Medxy AIja2026-10-04T04:30:19-07:00肥満女性の子宮内膜がん検出における新規バイオマーカーとしての血清GLP-1 https://news.medxy.ai/vi/glp-1-biomarker-cancer/Medxy AIvi2026-10-04T04:30:00-07:00GLP-1 huyết thanh: dấu ấn sinh học mới đầy hứa hẹn trong phát hiện ung thư nội mạc tử cung ở phụ nữ béo phì https://news.medxy.ai/serum-glp-1-as-a-novel-biomarker-for-endometrial-cancer-detection-in-obese-women/Medxy AIen2026-10-04T04:29:41-07:00Serum GLP-1 as a Novel Biomarker for Endometrial Cancer Detection in Obese Women https://news.medxy.ai/zh/us-uterus-transplant-review/Medxy AIzh2026-10-04T04:29:02-07:00美国子宫移植10年回顾：手术安全、生殖里程碑与儿童发育结局 https://news.medxy.ai/ja/us-10-year-uterus-transplant/Medxy AIja2026-10-04T04:28:41-07:00米国の10年にわたる子宮移植：手術成績・生殖転帰・小児発達の検証 https://news.medxy.ai/vi/womb-transplant-success/Medxy AIvi2026-10-04T04:28:17-07:00Ghép tử cung sau 10 năm tại Hoa Kỳ: Thành công phẫu thuật, cột mốc sinh sản và kết cục phát triển của trẻ https://news.medxy.ai/ten-years-of-uterus-transplantation-in-the-us-surgical-success-reproductive-milestones-and-child-development-outcomes/Medxy AIen2026-10-04T04:27:57-07:00Ten Years of Uterus Transplantation in the US: Surgical Success, Reproductive Milestones, and Child Development Outcomes https://news.medxy.ai/zh/80651-2/Medxy AIzh2026-10-04T04:27:15-07:00产前检查数据与指标的更新以改善妊娠结局 https://news.medxy.ai/ja/pregnancy-outcomes-update/Medxy AIja2026-10-04T04:26:49-07:00妊娠転帰を高める妊婦健診データ・指標の刷新：包括的エビデンス統合 https://news.medxy.ai/vi/better-prenatal-care/Medxy AIvi2026-10-04T04:26:23-07:00Nâng cao kết cục thai kỳ bằng dữ liệu và chỉ số chăm sóc trước sinh tốt hơn: Tổng hợp bằng chứng toàn diện https://news.medxy.ai/improving-pregnancy-outcomes-through-enhanced-prenatal-care-data-and-metrics-a-comprehensive-evidence-synthesis/Medxy AIen2026-10-04T04:25:57-07:00Improving Pregnancy Outcomes Through Enhanced Prenatal Care Data and Metrics: A Comprehensive Evidence Synthesis https://news.medxy.ai/zh/liver-transplantation-immune-control/Medxy AIzh2026-10-04T04:24:58-07:00肝移植中的先天免疫炎症控制：HOPE 与 NMP 机器灌注的启示 https://news.medxy.ai/ja/liver-transplant-immunity/Medxy AIja2026-10-04T04:24:40-07:00肝移植における自然免疫応答をどう抑えるか：HOPEとNMP機械灌流が示す新知見 https://news.medxy.ai/vi/innate-immunity-liver-transplant/Medxy AIvi2026-10-04T04:24:15-07:00Giảm đáp ứng miễn dịch bẩm sinh trong ghép gan: Những hiểu biết từ HOPE và tưới máu máy NMP https://news.medxy.ai/mitigating-innate-immune-response-in-liver-transplantation-insights-from-hope-and-nmp-machine-perfusion/Medxy AIen2026-10-04T04:23:54-07:00Mitigating Innate Immune Response in Liver Transplantation: Insights from HOPE and NMP Machine Perfusion https://news.medxy.ai/zh/80629-2/Medxy AIzh2026-10-04T04:23:04-07:00医源性脑淀粉样血管病：长期病程与临床意义 https://news.medxy.ai/ja/80628-2/Medxy AIja2026-10-04T04:22:45-07:00医療介入に関連するアミロイド脳血管障害：長期経過と臨床的意義 https://news.medxy.ai/vi/amyloid-cerebral-disease/Medxy AIvi2026-10-04T04:22:24-07:00Bệnh não mạch amyloid do can thiệp y khoa: diễn tiến dài hạn và ý nghĩa lâm sàng https://news.medxy.ai/unraveling-iatrogenic-cerebral-amyloid-angiopathy-long-term-disease-progression-and-clinical-implications/Medxy AIen2026-10-04T04:22:04-07:00Unraveling Iatrogenic Cerebral Amyloid Angiopathy: Long-Term Disease Progression and Clinical Implications https://news.medxy.ai/zh/hearing-aid-cognition/Medxy AIzh2026-10-04T04:21:23-07:00助听器干预能否延缓轻度认知障碍老年人认知恶化？CHOICE随机临床试验给出新证据 https://news.medxy.ai/ja/hearing-aid-intervention/Medxy AIja2026-10-04T04:21:06-07:00軽度認知障害を有する高齢者における補聴器介入の評価：CHOICEランダム化臨床試験からの知見 https://news.medxy.ai/vi/hearing-aids-dementia/Medxy AIvi2026-10-04T04:20:47-07:00Máy trợ thính có giúp làm chậm sa sút trí tuệ ở người cao tuổi bị suy giảm nhận thức nhẹ? Bằng chứng từ thử nghiệm CHOICE https://news.medxy.ai/evaluating-hearing-aid-intervention-in-older-adults-with-mild-cognitive-impairment-insights-from-the-choice-randomized-clinical-trial/Medxy AIen2026-10-04T04:20:27-07:00Evaluating Hearing Aid Intervention in Older Adults with Mild Cognitive Impairment: Insights from the CHOICE Randomized Clinical Trial https://news.medxy.ai/zh/thyroid-nodules-followup/Medxy AIzh2026-10-04T04:19:41-07:00偶发性甲状腺结节：超声随访模式及临床意义 https://news.medxy.ai/ja/80608-2/Medxy AIja2026-10-04T04:19:23-07:00偶発的甲状腺結節：超音波による経過観察の様式と臨床的意義 https://news.medxy.ai/vi/thyroid-nodule-surveillance/Medxy AIvi2026-10-04T04:19:04-07:00Nhân tuyến giáp phát hiện tình cờ: Mô hình theo dõi bằng siêu âm và ý nghĩa lâm sàng https://news.medxy.ai/incidental-thyroid-nodules-ultrasound-follow-up-patterns-and-clinical-implications/Medxy AIen2026-10-04T04:18:44-07:00Incidental Thyroid Nodules: Ultrasound Follow-up Patterns and Clinical Implications https://news.medxy.ai/zh/80602-2/Medxy AIzh2026-10-04T04:18:06-07:00GAD-alum能长期推迟HLA-DR3-DQ2阳性1型糖尿病儿童发病 https://news.medxy.ai/ja/type-1-diabetes-prevention/Medxy AIja2026-10-04T04:17:46-07:001型糖尿病予防における精密医療：GAD-alum治療後のHLA-DR3-DQ2陽性児でみられたステージ3発症の長期遅延 https://news.medxy.ai/vi/precision-medicine-diabetes/Medxy AIvi2026-10-04T04:17:22-07:00Y học chính xác trong phòng ngừa đái tháo đường týp 1: GAD-alum giúp trì hoãn đáng kể khởi phát giai đoạn 3 ở trẻ HLA-DR3-DQ2 dương tính https://news.medxy.ai/precision-medicine-in-type-1-diabetes-prevention-long-term-delayed-onset-of-stage-3-diabetes-after-gad-alum-treatment-in-hla-dr3-dq2-positive-children/Medxy AIen2026-10-04T04:16:58-07:00Precision Medicine in Type 1 Diabetes Prevention: Long-Term Delayed Onset of Stage 3 Diabetes After GAD-Alum Treatment in HLA-DR3-DQ2-Positive Children https://news.medxy.ai/zh/glp1-safety-pregnancy/Medxy AIzh2026-10-04T04:15:57-07:00法国全国性研究解读：2 型糖尿病孕妇使用 GLP-1 受体激动剂及新型降糖药的安全性 https://news.medxy.ai/ja/80587-2/Medxy AIja2026-10-04T04:15:38-07:002型糖尿病の妊婦におけるGLP-1受容体作動薬および新規血糖降下薬の使用の安全性 https://news.medxy.ai/vi/glp-1-safety-pregnancy/Medxy AIvi2026-10-04T04:15:14-07:00Đánh giá tính an toàn của chất chủ vận thụ thể GLP-1 và các thuốc hạ glucose thế hệ mới ở thai phụ mắc đái tháo đường týp 2: Góc nhìn từ một nghiên cứu toàn quốc tại Pháp https://news.medxy.ai/evaluating-the-safety-of-glp-1-receptor-agonists-and-new-generation-glucose-lowering-agents-in-pregnant-women-with-type-2-diabetes-insights-from-a-french-nationwide-study/Medxy AIen2026-10-04T04:14:54-07:00Evaluating the Safety of GLP-1 Receptor Agonists and New-Generation Glucose-Lowering Agents in Pregnant Women with Type 2 Diabetes: Insights from a French Nationwide Study https://news.medxy.ai/zh/morning-saliva-critone/Medxy AIzh2026-10-04T04:14:11-07:00清晨唾液皮质酮可作为肾上腺功能不全筛查的可靠无创指标：来自英国真实世界队列的研究洞见 https://news.medxy.ai/ja/adrenal-insufficiency-screening/Medxy AIja2026-10-04T04:13:52-07:00早朝唾液コルチゾンによる副腎不全スクリーニング：英国リアルワールドコホートからの知見 https://news.medxy.ai/vi/80580-2/Medxy AIvi2026-10-04T04:13:27-07:00Nồng độ cortisol trong nước bọt vào sáng sớm có thể đóng vai trò là dấu ấn sàng lọc tình trạng suy tuyến thượng thận https://news.medxy.ai/morning-salivary-cortisone-as-a-reliable-non-invasive-screen-for-adrenal-insufficiency-insights-from-a-real-world-uk-cohort/Medxy AIen2026-10-04T04:13:09-07:00Morning Salivary Cortisone as a Reliable Non-Invasive Screen for Adrenal Insufficiency: Insights from a Real-World UK Cohort https://news.medxy.ai/zh/nocode-ai-thyroid-cancer/Medxy AIzh2026-10-04T04:12:25-07:00无代码AI助力甲状腺结节超声恶性分类：迈向更易获取、可重复的医学AI https://news.medxy.ai/ja/no-code-ai-thyroid-ultrasound/Medxy AIja2026-10-04T04:12:04-07:00ノーコードAIで切り拓く甲状腺結節超音波悪性判定：誰もが使える再現可能な医療AIへ https://news.medxy.ai/vi/ai-thyroid-cancer-classification/Medxy AIvi2026-10-04T04:11:42-07:00Khai thác AI No-Code trong phân loại ác tính nốt tuyến giáp bằng siêu âm: Bước tiến tới AI y khoa dễ tiếp cận và có thể tái lập https://news.medxy.ai/harnessing-no-code-ai-for-thyroid-nodule-ultrasound-malignancy-classification-a-leap-toward-accessible-and-reproducible-medical-ai/Medxy AIen2026-10-04T04:11:21-07:00Harnessing No-Code AI for Thyroid Nodule Ultrasound Malignancy Classification: A Leap Toward Accessible and Reproducible Medical AI https://news.medxy.ai/zh/metabolic-status-vitamin-d/Medxy AIzh2026-10-04T04:10:36-07:00代谢状态会影响糖尿病前期患者对活性维生素D的骨骼反应：DPVD试验的新发现 https://news.medxy.ai/ja/80555-2/Medxy AIja2026-10-04T04:10:17-07:00代謝状態は糖尿病予備群における活性型ビタミンDへの骨反応に影響を及ぼす https://news.medxy.ai/vi/80552-2/Medxy AIvi2026-10-04T04:09:57-07:00Tình trạng chuyển hóa có thể ảnh hưởng đến việc sử dụng vitamin D dạng hoạt động ở bệnh nhân tiền đái tháo đường https://news.medxy.ai/metabolic-status-influences-bone-response-to-active-vitamin-d-in-prediabetes-insights-from-the-dpvd-trial/Medxy AIen2026-10-04T04:09:38-07:00Metabolic Status Influences Bone Response to Active Vitamin D in Prediabetes: Insights from the DPVD Trial https://news.medxy.ai/zh/obesity-type-1-diabetes/Medxy AIzh2026-10-04T04:08:54-07:00超重与肥胖青少年1型糖尿病部分缓解识别面临挑战：来自SEARCH for Diabetes in Youth研究的启示 https://news.medxy.ai/ja/partial-remission-diabetes/Medxy AIja2026-10-04T04:08:34-07:00小児1型糖尿病における部分寛解判定でIDAA1cはどこまで有用か：SEARCH for Diabetes in Youth研究からの示唆 https://news.medxy.ai/vi/idaa1c-relapse-diabetes-type-1/Medxy AIvi2026-10-04T04:08:14-07:00IDAA1c để nhận diện lui bệnh một phần ở trẻ mắc đái tháo đường typ 1: thách thức từ nghiên cứu SEARCH for Diabetes in Youth https://news.medxy.ai/challenges-in-using-insulin-dose-adjusted-hba1c-to-identify-partial-remission-in-pediatric-type-1-diabetes-insights-from-the-search-for-diabetes-in-youth-study/Medxy AIen2026-10-04T04:07:56-07:00Challenges in Using Insulin Dose-Adjusted HbA1c to Identify Partial Remission in Pediatric Type 1 Diabetes: Insights from the SEARCH for Diabetes in Youth Study https://news.medxy.ai/zh/type-1-diabetes-sleep-apnea/Medxy AIzh2026-10-04T04:07:12-07:001型糖尿病老年患者阻塞性睡眠呼吸暂停风险升高、睡眠质量下降：来自 DCCT/EDIC 队列的启示 https://news.medxy.ai/ja/sleep-apnea-risk-elderly-diabetes/Medxy AIja2026-10-04T04:06:53-07:00高齢の1型糖尿病患者における閉塞性睡眠時無呼吸リスクと睡眠の質低下の増大：DCCT/EDICコホートからの知見 https://news.medxy.ai/vi/sleep-apnea-diabetes/Medxy AIvi2026-10-04T04:06:32-07:00Nguy cơ ngưng thở tắc nghẽn khi ngủ và chất lượng giấc ngủ kém tăng ở người lớn tuổi mắc đái tháo đường týp 1: Góc nhìn từ đoàn hệ DCCT/EDIC https://news.medxy.ai/increased-risk-of-obstructive-sleep-apnea-and-poor-sleep-quality-among-older-adults-with-type-1-diabetes-insights-from-the-dcct-edic-cohort/Medxy AIen2026-10-04T04:06:11-07:00Increased Risk of Obstructive Sleep Apnea and Poor Sleep Quality Among Older Adults With Type 1 Diabetes: Insights from the DCCT/EDIC Cohort https://news.medxy.ai/zh/petrelintide-obesity-management/Medxy AIzh2026-10-04T04:05:19-07:00Petrelintide：一种用于长期肥胖管理、前景可观的人胰淀素类似物 https://news.medxy.ai/ja/petrelintide-obesity-management-2/Medxy AIja2026-10-04T04:05:01-07:00Petrelintide、長期肥満管理に向けた有望なヒトアミリン類似体 https://news.medxy.ai/vi/petrelintide-amylin-obesity/Medxy AIvi2026-10-04T04:04:40-07:00Petrelintide: Chất tương tự amylin ở người đầy hứa hẹn cho kiểm soát béo phì lâu dài https://news.medxy.ai/petrelintide-a-promising-human-amylin-analogue-for-long-term-obesity-management/Medxy AIen2026-10-04T04:04:21-07:00Petrelintide: A Promising Human Amylin Analogue for Long-Term Obesity Management https://news.medxy.ai/zh/heartbit-transcriptomic-biomarker/Medxy AIzh2026-10-04T04:03:41-07:00HEARTBiT：一种用于心脏移植后早期急性细胞排斥反应检出的突破性转录组学生物标志物 https://news.medxy.ai/ja/heartbit-biomarker/Medxy AIja2026-10-04T04:03:21-07:00心臓移植後早期拒絶反応を捉える新規バイオマーカー「HEARTBiT」— トランスクリプトーム解析で切り開く低侵襲診断 https://news.medxy.ai/vi/heartbit-transcription-biomarker/Medxy AIvi2026-10-04T04:03:00-07:00HEARTBiT: Dấu ấn sinh học phiên mã học đột phá giúp phát hiện sớm thải ghép tế bào cấp tính sau ghép tim https://news.medxy.ai/heartbit-a-breakthrough-transcriptomic-biomarker-for-early-detection-of-acute-cellular-rejection-post-heart-transplantation/Medxy AIen2026-10-04T04:02:39-07:00HEARTBiT: A Breakthrough Transcriptomic Biomarker for Early Detection of Acute Cellular Rejection Post-Heart Transplantation https://news.medxy.ai/ja/cmr-cardiology-2026/Medxy AIja2026-10-04T04:01:57-07:00日常循環器診療にCMRをどう組み込むか――2026年EHJコンセンサスの要点 https://news.medxy.ai/vi/cmr-cardiology-practice/Medxy AIvi2026-10-04T04:01:19-07:00Đưa CMR vào thực hành tim mạch hằng ngày: các khuyến cáo then chốt từ đồng thuận EHJ 2026 https://news.medxy.ai/zh/cardiac-mri-guidelines/Medxy AIzh2026-10-04T04:00:45-07:00让心脏磁共振走进日常心内科：2026 年 EHJ 共识的关键建议 https://news.medxy.ai/bringing-cardiac-mri-into-everyday-cardiology-key-recommendations-from-the-2026-ehj-consensus/Medxy AIen2026-10-04T04:00:13-07:00Bringing Cardiac MRI into Everyday Cardiology: Key Recommendations from the 2026 EHJ Consensus https://news.medxy.ai/zh/smoc-1-heart-protection/Medxy AIzh2026-10-04T03:58:58-07:00SMOC-1：预防急性心肌梗死后心脏破裂的新型保护因子 https://news.medxy.ai/ja/80513-2/Medxy AIja2026-10-04T03:58:40-07:00SMOC-1：急性心筋梗塞後の心臓破裂を予防する新規保護因子 https://news.medxy.ai/vi/80512-2/Medxy AIvi2026-10-04T03:58:19-07:00SMOC-1: Một yếu tố bảo vệ mới chống lại tình trạng vỡ tim sau nhồi máu cơ tim cấp https://news.medxy.ai/secreted-modular-calcium-binding-protein-1-a-novel-protective-factor-to-prevent-cardiac-rupture-post-acute-myocardial-infarction/Medxy AIen2026-10-04T03:57:58-07:00Secreted Modular Calcium-Binding Protein 1: A Novel Protective Factor to Prevent Cardiac Rupture Post-Acute Myocardial Infarction https://news.medxy.ai/zh/tavr-stroke-rate/Medxy AIzh2026-10-04T03:57:15-07:00TAVR后卒中率为何“看起来更高”？医院卒中中心资质对质量评估的影响 https://news.medxy.ai/ja/tavr-stroke-rates/Medxy AIja2026-10-04T03:56:53-07:00TAVR後の脳卒中率報告は病院の脳卒中センター認定に左右される：質評価への示唆 https://news.medxy.ai/vi/stroke-center-quality/Medxy AIvi2026-10-04T03:56:27-07:00Trung tâm Đột quỵ của Bệnh viện Có Thể Làm Thay Đổi Tỷ Lệ Đột Quỵ Sau TAVR Được Báo Cáo: Hàm Ý Cho Đánh Giá Chất Lượng https://news.medxy.ai/hospital-stroke-center-designation-influences-reported-stroke-rates-after-tavr-implications-for-quality-assessment/Medxy AIen2026-10-04T03:56:05-07:00Hospital Stroke Center Designation Influences Reported Stroke Rates After TAVR: Implications for Quality Assessment https://news.medxy.ai/zh/aortic-aneurysm-mechanisms/Medxy AIzh2026-10-04T03:55:22-07:00揭开腹主动脉瘤的机制：表观遗传学与炎症、脂质代谢的关联 https://news.medxy.ai/ja/abdominal-aortic-aneurysm/Medxy AIja2026-10-04T03:55:02-07:00腹部大動脈瘤の病態を解く：炎症と脂質代謝をつなぐエピジェネティクス https://news.medxy.ai/vi/80502-2/Medxy AIvi2026-10-04T03:54:39-07:00Giải mã cơ chế bệnh phình động mạch chủ bụng: Sự tương tác giữa di truyền ngoại gen, tình trạng viêm và chuyển hóa lipid https://news.medxy.ai/unraveling-abdominal-aortic-aneurysm-epigenetic-links-to-inflammation-and-lipid-metabolism/Medxy AIen2026-10-04T03:54:17-07:00Unraveling Abdominal Aortic Aneurysm: Epigenetic Links to Inflammation and Lipid Metabolism https://news.medxy.ai/zh/80491-2/Medxy AIzh2026-10-04T03:23:42-07:00再灌注后的微血管功能障碍可预测进展性脑梗死及不良预后 https://news.medxy.ai/ja/80490-2/Medxy AIja2026-10-04T03:23:13-07:00再灌流後の微小循環障害は、脳梗塞の進行および予後不良を予測する可能性がある https://news.medxy.ai/vi/microvascular-disorder-predicts-stroke/Medxy AIvi2026-10-04T03:22:41-07:00Rối loạn vi mạch sau tái tưới máu có thể dự báo nhồi máu đột quỵ tiến triển và tiên lượng xấu https://news.medxy.ai/microvascular-dysfunction-after-reperfusion-predicts-stroke-infarct-expansion-and-poor-outcomes/Medxy AIen2026-10-04T03:22:11-07:00Microvascular Dysfunction After Reperfusion Predicts Stroke Infarct Expansion and Poor Outcomes https://news.medxy.ai/zh/youth-mental-health-service-use/Medxy AIzh2026-10-04T03:21:24-07:00远离家乡接受精神科住院治疗后，青年医疗服务利用的变化：来自英格兰及相关研究证据的综合综述 https://news.medxy.ai/ja/psychiatric-hospitalization-impact/Medxy AIja2026-10-04T03:20:57-07:00遠隔地での精神科入院後、若年者の医療利用はどう変わるのか：イングランドのエビデンスと関連研究を総覧する https://news.medxy.ai/vi/mental-health-service-use/Medxy AIvi2026-10-04T03:20:23-07:00Sử dụng dịch vụ y tế ở người trẻ sau khi nhập viện sức khỏe tâm thần xa nhà: Tổng quan toàn diện bằng chứng từ Anh và các nghiên cứu liên quan https://news.medxy.ai/health-service-use-in-young-people-following-mental-health-admission-far-from-home-a-comprehensive-review-of-evidence-from-england-and-related-studies/Medxy AIen2026-10-04T03:19:52-07:00Health Service Use in Young People Following Mental Health Admission Far from Home: A Comprehensive Review of Evidence from England and Related Studies https://news.medxy.ai/zh/pertussis-antibiotic-evidence/Medxy AIzh2026-10-03T08:08:51-07:00百日咳婴儿抗菌治疗新证据：意大利医院真实世界研究显示克拉霉素优于阿奇霉素 https://news.medxy.ai/ja/79982-2/Medxy AIja2026-10-03T08:08:33-07:00百日咳の乳児において、クラリスロマイシンはアジスロマイシンより優れている https://news.medxy.ai/vi/79978-2/Medxy AIvi2026-10-03T08:08:09-07:00Các nghiên cứu thực tế cho thấy clarithromycin vượt trội hơn azithromycin ở trẻ nhũ nhi mắc bệnh ho gà https://news.medxy.ai/clarithromycin-vs-azithromycin-for-infant-pertussis-real-world-outcomes-from-italian-hospitals/Medxy AIen2026-10-03T08:07:49-07:00Clarithromycin vs Azithromycin for Infant Pertussis: Real-World Outcomes from Italian Hospitals https://news.medxy.ai/zh/pcv-vaccine-followup/Medxy AIzh2026-10-03T08:07:04-07:00南非肺炎球菌结合疫苗加强免疫后最长追踪至5岁：PCV10与PCV13婴儿1+1及2+1程序的随机对照试验延长随访 https://news.medxy.ai/ja/pneumococcal-vaccine-study/Medxy AIja2026-10-03T08:06:39-07:00南アフリカにおける10価・13価肺炎球菌結合型ワクチンの乳児初回接種後、5歳までの免疫原性：ブースター追加を伴う延長RCT追跡 https://news.medxy.ai/vi/pcv13-immunity-children/Medxy AIvi2026-10-03T08:06:16-07:00Miễn dịch của PCV13 kéo dài đến 5 tuổi sau lịch tiêm 1 hoặc 2 liều khởi đầu ở trẻ nhỏ kèm liều nhắc tại Nam Phi: theo dõi mở rộng của thử nghiệm ngẫu nhiên có đối chứng https://news.medxy.ai/immunogenicity-up-to-age-5-following-single-or-two-dose-infant-primary-series-of-10-valent-and-13-valent-pneumococcal-conjugate-vaccine-with-booster-in-south-africa-extended-rct-follow-up/Medxy AIen2026-10-03T08:05:54-07:00Immunogenicity up to Age 5 Following Single- or Two-Dose Infant Primary Series of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine with Booster in South Africa: Extended RCT Follow-Up https://news.medxy.ai/health-service-utilization-among-young-people-following-out-of-area-mental-health-admissions-evidence-from-a-retrospective-cohort-study-in-england/Medxy AIen2026-10-03T08:00:12-07:00Health Service Utilization Among Young People Following Out-of-Area Mental Health Admissions: Evidence from a Retrospective Cohort Study in England https://news.medxy.ai/zh/extremely-preterm-birth/Medxy AIzh2026-10-03T07:59:21-07:00超早产与极低出生体重人群成年福祉的儿童期预测因素：一项34年队列研究的启示 https://news.medxy.ai/ja/early-birth-wellbeing/Medxy AIja2026-10-03T07:59:03-07:00超早産・超低出生体重で生まれた人の成人ウェルビーイングを左右する小児期予測因子：34年コホート研究からの知見 https://news.medxy.ai/vi/childhood-predictors-health/Medxy AIvi2026-10-03T07:58:41-07:00Những yếu tố dự báo từ thời thơ ấu đối với sức khỏe và thích nghi tốt ở tuổi trưởng thành ở người sinh cực non và/hoặc có cân nặng lúc sinh rất thấp: phát hiện từ nghiên cứu đoàn hệ 34 năm https://news.medxy.ai/childhood-predictors-of-adult-well-being-in-very-preterm-and-very-low-birth-weight-individuals-insights-from-a-34-year-cohort-study/Medxy AIen2026-10-03T07:58:19-07:00Childhood Predictors of Adult Well-Being in Very Preterm and Very Low Birth Weight Individuals: Insights From a 34-Year Cohort Study